Excel Sheet Made by Amol

CAPLIN POINT LABORATORIES LTD All figures in Rs crores

PROFIT & LOSS STATEMENT
Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 TTM COMMON SIZE P&L STATEMENT
y-o-y Sales Growth % -4% 48% 25% 26% -2% -9% 9% 0% 18% 15% Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 TTM
Sales 240 231 342 427 537 528 483 528 529 625 718
Raw Material Cost 128 117 162 180 237 238 195 205 198 205 - 53% 50% 47% 42% 44% 45% 40% 39% 37% 33%
Power and Fuel 8 8 10 11 12 7 6 10 10 15 3% 3% 3% 3% 2% 1% 1% 2% 2% 2%
Other Mfr. Exp 10 9 16 15 16 9 8 11 14 25 4% 4% 5% 4% 3% 2% 2% 2% 3% 4%
Gross Profit 94 98 154 220 272 273 274 303 307 379 Gross Margin 39% 42% 45% 52% 51% 52% 57% 57% 58% 61%

Employee Cost 18 18 31 39 42 25 27 30 37 38 8% 8% 9% 9% 8% 5% 6% 6% 7% 6%
Selling and admin 14 12 27 37 39 38 28 44 40 40 6% 5% 8% 9% 7% 7% 6% 8% 8% 6%
Other Expenses 5 5 2 2 2 3 5 9 10 13 2% 2% 1% 0% 0% 1% 1% 2% 2% 2% Chart of Op.EBIT Margin
Depreciation 8 7 13 19 21 20 22 26 26 27 26 3% 3% 4% 4% 4% 4% 5% 5% 5% 4%
Operating Profit (Op. EBIT) 49 55 81 123 168 187 192 194 195 261 289 Op.EBIT Margin 20% 24% 24% 29% 31% 36% 40% 37% 37% 42% 40%

Other Income 3 3 13 23 35 66 19 56 99 105 130 1% 2% 4% 5% 7% 12% 4% 11% 19% 17%

Interest 1 0 1 1 1 0 0 0 0 0 0 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Profit before tax 51 58 93 146 203 253 210 250 293 366 418 Chart of PAT Margin
Tax 10 13 22 44 54 55 54 62 59 82 96
PROFIT AFTER TAX (PAT) 41 45 70 102 148 198 156 188 234 284 323 PAT Margin 17% 20% 21% 24% 28% 37% 32% 36% 44% 45% 45%
Effective Income Tax Rate 19% 22% 24% 30% 27% 22% 26% 25% 20% 22%

Marginal Income Tax Rate #N/A 34.61% 34.61% 35.00% 30.00% 25.17% 25.17% 25.17% 25.17% #N/A
MARGINAL INCOME TAX DATA
GROWTH ANALYSIS Source KPMG for the years from 2011 until 2019
SALES Op. EBIT PAT from FY20 onwards, it is assumed that domestic companies will take advantage of Section 115BAA
9 Year CAGR 11% 20% 24% Mar-11 32.44%
7 Year CAGR 9% 18% 22% Mar-12 32.45%
5 Year CAGR 3% 9% 14% Mar-13 33.99%
3 Year CAGR 9% 11% 22% Mar-14 33.99%
TTM CAGR 15% 11% 14% Mar-15 34.61%
Mar-16 34.61%
Mar-17 34.61%
DEBT & SOLVENCY RATIOS Mar-18 35.00%
Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 Mar-19 30.00%
Debt 2 2 1 1 1 2 1 1 1 1 Mar-20 25.17%
Equity 94 128 200 296 432 600 759 931 1,140 1,390 Mar-21 25.17%
Mar-22 25.17%
Debt Coverage Ratios (Lower is Better) Mar-23 25.17%
Debt/Equity Ratio 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Debt/EBITDA 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0

Interest Expense / Debt 42% 16% 68% 98% 93% 8% 13% 15% 9% 11%

Interest Coverage Ratios (Higher is better)

Op. EBIT/Interest 56.3 178.1 161.1 237.0 335.5 986.3 1,126.8 2,157.3 1,621.9 2,606.1
EBITDA/Interest 65.8 201.7 187.7 273.6 377.2 1,089.7 1,258.8 2,443.7 1,835.7 2,876.9

NET DEBT (as at) Mar-24

Outstanding Debt 1
- Investments - Investments of 584 NOT deducted from debt. Deduct it, only if it is liquid. Check from Annual Report
- Cash & Bank 216
Net Outstanding Debt -215 This is a GOOD thing. It means that the company has no net debt as its cash reserves exceeds debt

FREE CASH FLOW

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
CASH FROM OPERATIONS 44 55 23 107 87 295 231 157 111
- CAPEX -8 -25 -48 17 -44 -36 -7 -60 -21 Chart of FCFF
- Tax Benefit from Interest (Int x Tax) -0 -0 -0 -0 -0 -0 -0 -0 #N/A
FREE CASH FLOW TO FIRM (FCFF) 36 30 -26 125 43 259 224 97 #N/A

- Interest -0 -1 -1 -1 -0 -0 -0 -0 -0
+ Tax Benefit from Interest (Int x Tax) 0 0 0 0 0 0 0 0 #N/A
- Debt Repayment -0 -1 -0 - - -1 -1 - -0
+ New Debt - - - 0 2 - - 1 -
FREE CASH FLOW TO EQUITY (FCFE) 36 28 -27 124 45 258 223 98 #N/A

FREE CASH FLOW OVER 9 YEARS FROM Mar-16 UNTIL Mar-24

Total CFO - Int Tax Shield #N/A (Cum CFO - Interest)/Cum PAT 78% (ideally, should be more than 75%. Higher the better)
- Total Capex -232
TOTAL FCFF #N/A Cum FCFF/Cum EBIAT #N/A
(Payout Ratio)
- Total Interest + Int Tax Benefit #N/A
Total FCFE through operations #N/A

Repayment of Debt -1
TOTAL FCFE #N/A
#N/A
Total Dividends in 9 yrs 196 #N/A

CASH FLOW STATEMENT

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 TOTAL
Cash from Operating Activity 50 44 55 23 107 87 295 231 157 111 1,160
Cash from Investing Activity -24 -6 -37 -60 -76 -41 -4 -276 -86 -118 -727
Cash from Financing Activity -9 -14 -7 -12 -15 -33 -3 -23 -30 -34 -180
Net Cash Flow 17 24 12 -49 16 13 287 -68 41 -41 253

VALUATION MULTIPLES
Based on Equity Value
Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 2.3.25
No. of shares (in crores) 8 8 8 8 8 8 8 8 8 8 8
EPS 5 6 9 14 20 26 21 25 31 37 43
Stock Price 186 202 388 570 402 282 403 678 596 1,315 1,823 1/(P/E) Current Bond Yield
P / ETTM 34.4 33.7 41.8 42.1 20.5 10.8 19.5 27.4 19.3 35.2 42.8 2% 10% no margin of safety

Book Value / Share 12.4 16.9 26.5 39.1 57.1 79.4 100.4 122.8 150.2 183.2 183.2
P/B 15.0 11.9 14.7 14.6 7.0 3.6 4.0 5.5 4.0 7.2 10.0

BASED ON ENTERPRISE VALUE Based on Enterprise Value

Debt - Cash -38 -63 -76 -28 -44 -56 -344 -315 -270 -215 Put updated figures
Enterprise Value (EV) 1,371 1,465 2,860 4,278 2,993 2,079 2,706 4,825 4,253 9,769 -
EBIT 52 59 93 147 203 253 210 250 293 366 419
EV / EBITTTM 26.5 25.0 30.7 29.2 14.7 8.2 12.9 19.3 14.5 26.7

EBITDA 60 66 106 166 224 273 233 276 319 393 444
EV / EBITDATTM 22.9 22.2 26.9 25.8 13.4 7.6 11.6 17.5 13.3 24.9

EV / Sales 5.7 6.3 8.4 10.0 5.6 3.9 5.6 9.1 8.0 15.6

DIVIDENDS
Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 2.3.25
Dividends (Rs crores) 8 9 11 15 17 19 23 30 34 38

Dividends/Net Profit 18% 20% 16% 15% 11% 10% 15% 16% 15% 13%
Dividends/Share 1.0 1.2 1.5 2.0 2.2 2.5 3.0 4.0 4.5 5.0
Stock Dividend Yield 1% 1% 0% 0% 1% 1% 1% 1% 1% 0% 0%

% RETURN IF YOU PURCHASED THE STOCK IN THE PAST AND SOLD IT TODAY
INPUT Date of Purchase Mar/20

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 2.3.25
Stock Bought - - - - - -282 - - - -
Dividends - - - - - 2.5 3.0 4.0 4.5 5.0
Stock Sold 1,823
Total - - - - - -280 3 4 5 5 1,823

IRR 47.0%

NOTE: The IRR calculated above DOES NOT account for buybacks, if any, by a company

Free CF yield / Acquirer's multiple Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
FCFF - 36 30 -26 125 43 259 224 97 #N/A
EV 1,371 1,465 2,860 4,278 2,993 2,079 2,706 4,825 4,253 9,769
FCFF / EV 0% 2% 1% -1% 4% 2% 10% 5% 2% #N/A #N/A
Acquirer's multiple 28.02 26.52 35.50 34.71 17.84 11.09 14.13 24.85 21.85 37.48

Fragility Scorecard
Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Total equity 93.63 128.14 200.12 295.6 432.05 599.91 758.67 930.65 1139.91 1390.15
Total liabilities 223.21 262.6 317.06 410.81 539.32 691.33 860.99 1054.16 1303.18 1,522
Equity as % total liabilities 42% 49% 63% 72% 80% 87% 88% 88% 87% 91% [Higher the better]

Interest + Depreciation 9.15 7.61 13.76 19.51 21.34 19.84 22.61 25.86 25.77 27.18
Operating profit % 20% 24% 24% 29% 31% 36% 40% 37% 37% 42%
Break even sales 44.914272578668 31.874626947 58.330991684 67.518908811 68.297922 55.88423715246 56.974131036283 70.33185 69.990647382 65.192994
Actual sales 240 231 342 427 537 528 483 528 529 625
Break even sales as % of sales 19% 14% 17% 16% 13% 11% 12% 13% 13% 10% [Lower the better]

ROIC 0% 419% 328% 92% 76% 72% 68% 94% 101% 104% [Higher the better]

Cash from operating activities 50 44 55 23 107 87 295 231 157 111

Interest + Depreciation 9.15 7.61 13.76 19.51 21.34 19.84 22.61 25.86 25.77 27.18
20% of borrowings 0.416 0.4 0.146 0.106 0.108 0.482 0.266 0.124 0.268 0.186
Yearly debt obligations as a % of cash flow from 5.18 5.54 3.99 1.15 5.00 4.28 12.88 8.89 6.03 4.06 [Higher the better]

Fragility Scorecard (my assessment)

Equity as % of total liabilities 1

Breakeven sales as % of total sales 1
ROIC 1
Yearly debt obligations as % of CFO 1
Total score 4

Self Sustainable Growth Rate (SSGR) - Dr Vijay Malik

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
NFA 111.47 142.75 151.75 169.32 138 167 183 162 157 166
NFAT (Net fixed asset turnover) 1.82 2.32 2.66 3.50 3.46 2.76 3.06 3.31 3.87
Average NFAT over 3 years 2.27 2.82 3.21 3.24 3.10 3.04 3.42
NPM 17% 20% 21% 24% 28% 37% 32% 36% 44% 45%
Average NPM of 3 years 21% 24% 30% 32% 35% 37% 42%
Dividend Payout Ratio 18% 20% 16% 15% 11% 10% 15% 16% 15% 13%
Average DPR 17% 14% 12% 12% 13% 15% 15%
Depreciation as % of NFA 7% 5% 9% 11% 15% 12% 12% 16% 16% 16%
Average Dep 8% 12% 13% 13% 13% 15% 16%
SSGR 32% 47% 71% 80% 81% 82% 105%

Average SSGR 89%

Average Sales Growth 9%
SSGR > Sales Growth yes and it's an awesome thing
 Excel Sheet Made by Amol
CAPLIN POINT LABORATORIES LTD
(all figures in Rs crores) BALANCE SHEET COMMON SIZE BALANCE SHEET
Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24 Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Equity Share Capital 15 15 15 15 15 15 15 15 15 15 7% 6% 5% 4% 3% 2% 2% 1% 1% 1%
Reserves 79 113 185 280 417 585 744 915 1,125 1,375 35% 43% 58% 68% 77% 85% 86% 87% 86% 90%
Borrowings 2 2 1 1 1 2 1 1 1 1 1% 1% 0% 0% 0% 0% 0% 0% 0% 0%
Trade Payables (Manually copy 146 156 155 138 132 171 129 130 163 196 65% 59% 49% 34% 24% 25% 15% 12% 13% 13%
Other Liabilities -19 -24 -39 -23 -25 -82 -28 -7 -1 -65 -8% -9% -12% -6% -5% -12% -3% -1% 0% -4%
TOTAL LIABILITIES 223 263 317 411 539 691 861 1,054 1,303 1,522 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

Net Block 111 143 152 169 138 167 183 162 157 166 50% 54% 48% 41% 26% 24% 21% 15% 12% 11%
Capital Work in Progress 31 0 3 15 9 4 1 3 43 28 14% 0% 1% 4% 2% 1% 0% 0% 3% 2%
Cash & Bank 40 65 77 28 45 58 345 316 271 216 18% 25% 24% 7% 8% 8% 40% 30% 21% 14%
Investments 1 1 19 48 168 196 149 265 485 584 1% 1% 6% 12% 31% 28% 17% 25% 37% 38%
Inventory 13 18 22 28 24 22 25 43 52 86 6% 7% 7% 7% 4% 3% 3% 4% 4% 6%
Receivables 0 7 3 86 125 219 98 54 88 129 0% 3% 1% 21% 23% 32% 11% 5% 7% 8%
Loans & Advances (Manually co 2 3 2 3 2 21 41 2 2 1 1% 1% 1% 1% 0% 3% 5% 0% 0% 0%
Other Assets 25 26 39 32 29 4 18 210 205 313 11% 10% 12% 8% 5% 1% 2% 20% 16% 21%
TOTAL ASSETS 223 263 317 411 539 691 861 1,054 1,303 1,522 100% 100% 100% 100% 100% 100% 100% 100% 100% 100%

FUND FLOW ANALYSIS

5 YEAR 1 YEAR
Equity Share Capital 0 0
Reserves 958 250
Borrowings 0 -0
Trade Payables 64 33
Other Liabilities -40 -64
TOTAL CHANGE IN LIABILITIES 983 219

Net Block + WIP 47 -6

Cash & Bank 171 -56
Investments 416 99
Inventory 63 35
Receivables 3 40
Loans & Advances -1 -1
Other Assets 284 108
TOTAL CHANGE IN ASSETS 983 219

FROM THE LIABILITY SIDE RETURN ON AVERAGE INVESTED CAPITAL (ROIC)

Jun-15 Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Operating EBIT 49 55 81 123 168 187 192 194 195 261 Median Min Max
Effective Tax Rate 19% 22% 24% 30% 27% 22% 26% 25% 20% 22% 23% 19% 30%
Operating EBIAT 39 43 61 86 123 146 143 146 156 202

Invested Capital from the Liability Side of Balance Sheet = (Book Value of Equity + Book Value of Debt - Cash)
Invested Capital 55 65 124 268 388 544 415 615 870 1,175
Average Invested Capital 60 95 196 328 466 479 515 743 1,023
Median Min Max
ROIC (EBIAT / Average Invested Capital) 71% 65% 44% 37% 31% 30% 28% 21% 20% 31% 20% 71%
with DuPont breakup
EBIAT/Sales 19% 18% 20% 23% 28% 30% 28% 29% 32% 28% 18% 32%
Sales/Av Invested Capital 3.8 3.6 2.2 1.6 1.1 1.0 1.0 0.7 0.6 1.1 0.6 3.8

FROM THE ASSET SIDE RETURN ON AVERAGE INVESTED CAPITAL (ROIC)

The section below breaks down ROIC into various components and thus allows us to use just one ratio-ROIC to measure it ALL operational parameters!
However it is helpful if you read a short note on this before using this section. Click HERE to read this short note
Please Manually Input the Trade Payables Data in 'Row 8' above from Screener.in BEFORE using this section

DATA NEEDED TO CALCULATE ROIC FROM THE ASSET SIDE

Net Working Capital -133 -131 -130 -23 17 70 -6 -33 -23 19
Average Net Working Capital -132 -130 -76 -3 44 32 -20 -28 -2
Median Min Max
Av Working Capital/Sales -57% -38% -18% -1% 8% 7% -4% -5% 0% -4% -57% 8%
Av Working Capital Turnover -1.7 -2.6 -5.6 -171.0 12.1 14.9 -27.0 -18.6 -290.1 -5.6 -290.1 14.9

Fixed Asset 142 143 155 185 146 171 184 165 200 194
Average Fixed Assets 143 149 170 166 159 177 175 182 197

Av Fixed Assets/Sales 62% 44% 40% 31% 30% 37% 33% 34% 31% 34% 30% 62%
Av Fixed Asset Turnover 1.6 2.3 2.5 3.2 3.3 2.7 3.0 2.9 3.2 2.9 1.6 3.3

Average Invested Capital from the Asset Side of Balance Sheet = Average Net Block & CWIP + Average Net Working Capital
Average Invested Capital 10 19 94 162 202 210 155 154 194

RETURN ON AVERAGE INVESTED CAPITAL (ROIC) with DETAILED BREAK-UP

Mar-16 Mar-17 Mar-18 Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24
Median Min Max Chart of Op. EBIT Margin
Operating EBIT Margin 24% 24% 29% 31% 36% 40% 37% 37% 42% 36% 24% 42%
Gross Margin 42% 45% 52% 51% 52% 57% 57% 58% 61%
- SG&A & Others -15% -18% -18% -16% -13% -12% -16% -16% -15%
- Depreciation -3% -4% -4% -4% -4% -5% -5% -5% -4%
Chart of Sales/Av Invested Capital
Sales/Av Invested Capital 22.6 18.3 4.6 3.3 2.6 2.3 3.4 3.4 3.2 3.4 2.3 22.6
Sales/Av Invested Capital is further broken down into Fixed Asset Turnover and Working Capital Turnover as below:

Av Fixed Asset Turnover 1.6 2.3 2.5 3.2 3.3 2.7 3.0 2.9 3.2

Av Working Capital Turnover -1.7 -2.6 -5.6 -171.0 12.1 14.9 -27.0 -18.6 -290.1
Average Inventory Days 24 21 22 18 16 18 23 33 40 Note: Inventory Days and Payable Days are calculated using Sales & not COGS
Average Receivable Days 5 5 38 72 119 120 53 49 63
Average Payable Days 238 166 125 92 105 113 90 101 105
Average Working Capital Cycle Days -209 -139 -65 -2 30 24 -14 -20 -1
Median Min Max Chart of ROIC Pre-Tax
ROIC Pre-Tax 540% 431% 132% 103% 93% 91% 125% 126% 134% 126% 91% 540%

Effective Tax Rate 22% 24% 30% 27% 22% 26% 25% 20% 22%
ROIC 419% 328% 92% 76% 72% 68% 94% 101% 104% 94% 68% 419%

NOTES:
1) The formula used for breaking up ROIC into its components is given in the adjacent image

2) To correctly calculate ROIC you need to several adjustments such as Identifying operating assets,
Capitalizing Operating & Financial Expenses, removing one-time & extra-ordinary items, adjusting taxes, etc
These adjustments are ESSENTIAL to get a correct measurement of ROIC or any other return such as ROE, ROA,
ROCE, etc. However, to do the same we need more granular level data from the Annual Report
HENCE, ROIC calculated without adjustments are ROUGH ESTIMATES of the actual return
 Input ONLY in Cells denoted as:

ROIC ESTIMATOR
Calculate the impact of ROIC of a company using your estimates of margins, tax and capital efficiency ratios

Historical Data of 9 years

Operating EBIT MARGIN Median
Gross Margin 52% 52%
- SG&A & Others -16% Input % as a negative number -16%
- Depreciation -4% Input % as a negative number -4%
1 Operating EBIT Margin 32%

Sales/Av Invested Capital

Fixed Asset Turnover 3.03 3.0

Working Capital Turnover -12.0

Average Inventory Days 22 22
Average Receivable Days 53 53
Average Payable Days 105 104.8129
Average Working Capital Cycle Days -31
2 Sales/Av Invested Capital 4.05

ROIC Pre-Tax ( 1 x 2) 129%

Effective Tax Rate 25% 24%

ROIC (Post Tax) 97%

1) Refer to the historical ranges of these inputs so that you make more informed estimates.
It is very much possible that you can have estimates higher/lower than the historical ranges.
But you should have strong reasons for doing so
2) Remember that these historical numbers are without adjustments as stated in the previous tab

CONVERTING ROIC TO ROE

Historical Data of 9 years
Median
Debt / Equity 0.00 0.00
Interest / Book Value of Debt 0.12 12%
Tax Rate 25% 23%
ROE 97%

NOTES:
1) The adjacent formula is used to convert ROIC (calculated from above) into ROE
capital efficiency ratios

Historical Data of 9 years

Min Max
42% 61%
-18% -12%
-5% -3%

2.7 3.3

16 40
5 120
89.51161 238.2939

20% 30%

previous tab

Historical Data of 9 years

Min Max
0.00 0.00
8% 93%
19% 30%
CAPLIN POINT LABORATORIES LTD
QUARTER ANALYSIS

Latest Quarter Latest 6 Months Period Latest 9 Months Period

Dec-24 Dec-23 Growth Latest Year Ago Growth Latest Year Ago Growth
Sales 185 133 39% 393 312 26% 579 486 19%
Expenses 108 70 218 159 322 256
Depreciation 6 7 13 13 19 20
Operating Profit 71 57 26% 163 139 17% 238 209 14%

Other Income 29 18 72 42 93 70
Interest 0 0 0 0 0 0
Profit before tax 94 68 222 168 313 259
Tax 25 19 54 44 79 65
Net profit 69 49 41% 168 124 35% 234 194 21%

EBIT Margin 39% 43% 41% 45% 41% 43%

EBITDA Margin 42% 48% 45% 49% 44% 47%
PAT Margin 37% 37% 43% 40% 40% 40%

Dec-24 Dec-23 Dec-22 Sep-24 Sep-23 Sep-22 Jun-24 Jun-23 Mar-24 Mar-23
Sales 185 133 131 208 179 137 186 174 139 145
39% 2% 16% 31% 7% -4%

Operating Profit 71 57 45 92 83 51 75 70 51 59
26% 26% 11% 63% 8% -13%
COMPANY NAME CAPLIN POINT LABORATORIES LTD
LATEST VERSION 2.10 PLEAS
CURRENT VERSION 2.10

META
Number of shares 7.60
Face Value 2.00
Current Price 1,822.50
Market Capitalization 13,853.13

PROFIT & LOSS

Report Date Jun-15 Mar-16 Mar-17 Mar-18
Sales 240.23 231.29 341.55 426.57
Raw Material Cost 129.49 117.04 162.17 182.50
Change in Inventory 1.24 0.31 0.23 2.39
Power and Fuel 8.39 7.55 9.85 10.96
Other Mfr. Exp 9.71 9.39 15.60 15.29
Employee Cost 18.38 18.13 30.58 38.82
Selling and admin 13.70 12.04 27.37 37.10
Other Expenses 4.58 4.93 2.38 2.04
Other Income 2.73 3.47 12.51 23.31
Depreciation 8.28 7.30 13.26 18.99
Interest 0.87 0.31 0.50 0.52
Profit before tax 50.80 58.38 92.58 146.05
Tax 9.86 13.05 22.26 43.74
Net profit 40.94 45.33 70.32 102.31
Dividend Amount 7.56 9.07 11.34 15.12

Quarters
Report Date Sep-22 Dec-22 Mar-23 Jun-23
Sales 136.95 130.60 144.67 173.66
Expenses 79.53 79.09 79.80 97.04
Other Income 22.45 29.36 12.22 27.27
Depreciation 6.51 6.47 6.29 6.67
Interest 0.04 0.04 0.03 0.03
Profit before tax 73.32 74.36 70.77 97.19
Tax 15.81 15.19 16.44 20.92
Net profit 57.51 59.17 54.33 76.27
Operating Profit 57.42 51.51 64.87 76.62

BALANCE SHEET
Report Date Jun-15 Mar-16 Mar-17 Mar-18
Equity Share Capital 15.11 15.11 15.12 15.12
Reserves 78.52 113.03 185.00 280.48
Borrowings 2.08 2.00 0.73 0.53
Other Liabilities 127.50 132.46 116.21 114.68
Total 223.21 262.60 317.06 410.81
Net Block 111.47 142.75 151.75 169.32
Capital Work in Progress 30.63 0.23 3.42 15.29
Investments 1.44 1.43 18.78 48.21
Other Assets 79.67 118.19 143.11 177.99
Total 223.21 262.60 317.06 410.81
Receivables 0.02 6.80 3.21 86.35
Inventory 12.66 17.90 22.29 28.46
Cash & Bank 40.32 64.77 76.66 28.28
No. of Equity Shares 15,110,000.00 15,110,000.00 75,576,750.00 75,603,500.00
New Bonus Shares
Face value 10.00 10.00 2.00 2.00

CASH FLOW:
Report Date Jun-15 Mar-16 Mar-17 Mar-18
Cash from Operating Activity 49.53 44.37 55.49 22.61
Cash from Investing Activity -23.76 -5.98 -37.07 -59.72
Cash from Financing Activity -8.62 -13.95 -6.74 -11.60
Net Cash Flow 17.15 24.45 11.67 -48.71

PRICE: 186.17 202.04 388.35 569.55

DERIVED:
Adjusted Equity Shares in Cr 7.56 7.56 7.56 7.56
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

536.91 527.83 482.68 528.06 528.61 625.09
239.54 238.92 195.40 213.65 199.73 248.90
2.51 0.74 0.57 9.00 1.67 43.68
12.29 7.19 6.36 9.54 9.89 15.43
15.56 8.98 7.75 10.81 13.73 25.43
42.01 25.00 26.59 30.47 36.68 38.11
39.24 38.19 28.12 43.51 40.30 39.86
2.18 3.25 5.04 9.15 9.67 13.35
35.40 65.93 18.56 56.24 98.64 105.23
20.84 19.65 22.44 25.77 25.65 27.08
0.50 0.19 0.17 0.09 0.12 0.10
202.66 253.13 209.94 250.31 293.15 365.74
54.49 55.49 53.71 62.44 58.89 82.03
148.17 197.64 156.23 187.87 234.26 283.71
16.64 18.91 22.70 30.32 34.16 37.98

Sep-23 Dec-23 Mar-24 Jun-24 Sep-24 Dec-24

179.22 132.83 139.38 185.64 207.93 185.23
89.77 69.51 81.70 104.26 109.77 107.84
24.49 17.90 36.18 21.50 43.01 28.83
6.72 6.76 6.93 6.18 6.49 6.01
0.02 0.03 0.02 0.02 0.02 0.04
107.20 74.43 86.91 96.68 134.66 100.17
25.10 18.98 17.03 24.14 28.92 25.46
 82.10 55.45 69.88 72.54 105.74 74.71
89.45 63.32 57.68 81.38 98.16 77.39

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

15.13 15.13 15.13 15.16 15.18 15.19
416.92 584.78 743.54 915.49 1,124.73 1,374.96
0.54 2.41 1.33 0.62 1.34 0.93
106.73 89.01 100.99 122.89 161.93 131.23
539.32 691.33 860.99 1,054.16 1,303.18 1,522.31
137.77 166.93 182.68 162.46 156.85 165.79
8.62 3.77 1.36 2.60 42.68 27.75
168.25 195.77 149.18 264.70 485.15 584.15
224.68 324.86 527.77 624.40 618.50 744.62
539.32 691.33 860.99 1,054.16 1,303.18 1,522.31
125.39 218.98 98.46 53.73 88.24 128.67
23.52 22.37 24.87 42.81 51.53 86.25
44.85 58.27 345.49 316.08 271.38 215.78
75,630,250.00 75,642,750.00 75,642,750.00 75,788,876.00 75,902,746.00 75,941,746.00

2.00 2.00 2.00 2.00 2.00 2.00

Mar-19 Mar-20 Mar-21 Mar-22 Mar-23 Mar-24

107.34 87.01 294.64 230.97 157.10 111.01
-75.79 -41.00 -3.90 -276.02 -85.67 -118.13
-15.21 -32.92 -3.47 -22.76 -30.42 -34.26
16.34 13.09 287.27 -67.81 41.01 -41.38

401.70 282.40 403.45 678.20 595.95 1,315.35

7.56 7.56 7.56 7.58 7.59 7.59